Skip to content
Homepage
Author:
SystImmune, Inc.
Posted Date:
June 22, 2026
SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China
SystImmune, Inc.
June 22, 2026
SystImmune Reports Phase 1 Data for BL-M14D1 Demonstrating Promising Activity in Small-Cell Lung Cancer at ASCO
SystImmune, Inc.
June 1, 2026
